Showing results (411-420 of 494) with videos related to
Sort By:
Pageof 50
Macromolecules|April 12, 2016
Influence of the Solvent Quality on Ring Polymer DimensionsSebastian Gooßen, Ana R Brás, Wim Pyckhout-Hintzen, et al.Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Isoprenoid modification of rab proteins terminating in CC or CXC motifsR Khosravi-Far, R J Lutz, A D Cox, et al.Stroke|December 22, 2020
Comprehensive Stroke Care and Outcomes: Time for a Paradigm ShiftPamela W Duncan, Cheryl Bushnell, Mysha Sissine, et al.Journal of Agricultural Safety and Health|April 2, 2011
Evaluating the protective capacity of two-post ROPS for a seat-belted occupant during a farm tractor overturnJ Guan, H Hsiao, J V Zwiener, et al.Mabs|February 5, 2014
Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft modelsKathleen R Whiteman, Holly A Johnson, Michele F Mayo, et al.Psychiatric Services (Washington, D.C.)|October 5, 2007
Fidelity outcomes in the National Implementing Evidence-Based Practices ProjectGregory J McHugo, Robert E Drake, Rob Whitley, et al.Investigative Ophthalmology & Visual Science|January 26, 2007
Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imagingStephanie H Kim, Craig J Galbán, Robert J Lutz, et al.Human Molecular Genetics|March 1, 1997
Perinatal lethality and multiple craniofacial malformations in MSX2 transgenic miceJ Winograd, M P Reilly, R Roe, et al.Clinical Endocrinology|September 10, 2008
Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetesM von Eynatten, D Liu, A Bluemm, et al.Cancer Research|April 19, 2006
Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processingHans K Erickson, Peter U Park, Wayne C Widdison, et al.Pageof 50